News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
37,757 Results
Type
Article (1778)
Company Profile (3)
Press Release (35976)
Section
Business (15634)
Career Advice (80)
Deals (2763)
Drug Delivery (3)
Drug Development (3891)
Employer Resources (3)
FDA (790)
Job Trends (822)
News (22205)
Policy (1210)
Tag
Academia (50)
Adcomms (1)
Allergies (5)
Alliances (1531)
ALS (10)
Alzheimer's disease (63)
Antibody-drug conjugate (ADC) (4)
Approvals (811)
Artificial intelligence (18)
Bankruptcy (16)
Best Places to Work (680)
Biosimilars (5)
Biotechnology (3)
Bladder cancer (6)
Breast cancer (43)
Cancer (231)
Cardiovascular disease (20)
Career advice (71)
Career pathing (1)
CAR-T (3)
CDC (1)
Cell therapy (12)
Cervical cancer (2)
Clinical research (3578)
Collaboration (36)
Compensation (47)
COVID-19 (65)
C-suite (7)
Cystic fibrosis (6)
Data (263)
Depression (2)
Diabetes (21)
Diagnostics (395)
Digital health (2)
Diversity, equity & inclusion (1)
Drug discovery (7)
Drug pricing (5)
Drug shortages (3)
Duchenne muscular dystrophy (8)
Earnings (13751)
Editorial (1)
Employer resources (2)
Events (3747)
Executive appointments (16)
FDA (1005)
Funding (45)
Gene editing (3)
Generative AI (1)
Gene therapy (14)
GLP-1 (50)
Government (111)
Guidances (126)
Healthcare (1040)
HIV (5)
Immunology and inflammation (6)
Immuno-oncology (2)
Indications (3)
Infectious disease (75)
Inflammatory bowel disease (12)
Influenza (3)
Intellectual property (5)
Interviews (20)
IPO (1911)
Job creations (192)
Job search strategy (42)
Labor market (8)
Layoffs (30)
Legal (252)
Liver cancer (2)
Lung cancer (47)
Lymphoma (37)
Manufacturing (26)
MASH (3)
Medical device (848)
Medtech (849)
Mergers & acquisitions (885)
Metabolic disorders (57)
Multiple sclerosis (7)
NASH (1)
Neurodegenerative disease (7)
Neuropsychiatric disorders (2)
Neuroscience (104)
NextGen: Class of 2025 (229)
Non-profit (124)
Obesity (36)
Opinion (4)
Ovarian cancer (7)
Pain (6)
Pancreatic cancer (13)
Parkinson's disease (5)
Partnered (1)
Patents (10)
Patient recruitment (3)
Peanut (4)
People (1108)
Phase I (826)
Phase II (1485)
Phase III (1447)
Pipeline (480)
Policy (1)
Postmarket research (178)
Preclinical (258)
Press Release (1)
Prostate cancer (3)
Psychedelics (1)
Radiopharmaceuticals (13)
Rare diseases (23)
Real estate (204)
Recruiting (2)
Regulatory (988)
Reports (5)
Research institute (54)
Resumes & cover letters (20)
RSV (3)
Schizophrenia (11)
Series A (4)
Series B (4)
Service/supplier (1)
Sickle cell disease (4)
Spinal muscular atrophy (15)
Startups (127)
Stomach cancer (1)
Supply chain (2)
Tariffs (3)
The Weekly (1)
Vaccines (20)
Venture capital (5)
Weight loss (20)
Women's health (1)
Date
Last 7 days (23)
Last 30 days (99)
Last 365 days (2282)
2025 (1622)
2024 (2553)
2023 (2683)
2022 (3033)
2021 (3030)
2020 (2816)
2019 (2109)
2018 (1733)
2017 (1544)
2016 (1167)
2015 (1394)
2014 (990)
2013 (690)
2012 (729)
2011 (844)
2010 (6529)
Location
Africa (29)
Alabama (3)
Arizona (10)
Asia (2105)
Australia (224)
California (604)
Canada (167)
China (46)
Colorado (29)
Connecticut (31)
Delaware (49)
Europe (4768)
Florida (82)
Georgia (25)
Idaho (4)
Illinois (57)
India (4)
Indiana (55)
Japan (21)
Kansas (5)
Kentucky (3)
Louisiana (4)
Maine (5)
Maryland (67)
Massachusetts (386)
Michigan (18)
Minnesota (29)
Missouri (3)
Montana (2)
Nebraska (1)
Nevada (2)
New Hampshire (9)
New Jersey (213)
New Mexico (2)
New York (205)
North Carolina (78)
Northern California (330)
Ohio (14)
Oregon (2)
Pennsylvania (142)
Puerto Rico (1)
Rhode Island (1)
South America (60)
South Carolina (5)
Southern California (198)
Tennessee (6)
Texas (68)
United States (2243)
Utah (23)
Virginia (5)
Washington D.C. (2)
Washington State (44)
Wisconsin (4)
37,757 Results for "125".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Merck Abandons $1.3B R&D Center in London, Boots 125 Employees
Claiming that the domestic market undervalues pharma innovation, Merck has decided to pull the plug on all of its R&D efforts in the U.K.
September 11, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Rallybio Receives $12.5 Million Equity Milestone Payment from Recursion for Advancement of REV102 Program
September 4, 2025
·
4 min read
Layoff Tracker
Merck To Cut 125 Employees as It Ends UK R&D Work
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
September 12, 2025
·
198 min read
·
BioSpace Editorial Staff
Press Releases
Stereotaxis Announces $12.5 Million Registered Direct Offering of Common Stock
July 18, 2025
·
4 min read
Press Releases
Myosin Therapeutics Awarded $4.5 Million NCI Bridge Grant to Advance Phase I Trial of MT-125 in Glioblastoma
August 19, 2025
·
2 min read
Press Releases
Oncomatryx Biopharma Awarded €12.5 Million EIC Accelerator Funding to Advance Groundbreaking ADCs
July 15, 2025
·
2 min read
Press Releases
TOLREMO therapeutics Receives Two FDA Fast Track Designations for TT125-802 in Pretreated, Advanced or Metastatic NSCLC With Either an EGFR or a KRAS-G12C Mutation
August 28, 2025
·
4 min read
Press Releases
ORIC® Pharmaceuticals Announces $125 Million Private Placement Financing
May 29, 2025
·
6 min read
Mergers & acquisitions
BioNTech Swallows Vaccine Rival CureVac in $1.25B All-Stock Acquisition
BioNTech will get CureVac’s early-stage cancer assets, including its mRNA-based glioblastoma therapy currently in Phase I development. CureVac had previously sued BioNTech for copyright infringement related to mRNA vaccine technology.
June 12, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Myosin Therapeutics Receives FDA Clearance to Initiate First-in-Human Trial of MT-125 in Glioblastoma
June 10, 2025
·
2 min read
1 of 3,776
Next
